MEDICINAL EXCELLENCE IN NEUROLOGICAL DISORDERS, LLC
a cannabinoid research company focused on the development of physician-formulated cannabinoid products
MEDICINAL EXCELLENCE IN NEUROLOGICAL DISORDERS, LLC
Status:
Active
More informations about "Medicinal Excellence in Neurological Disorders, LLC"
Medicinal Excellence in Neurological Disorders, LLC
A cannabinoid research company focused on the development of physician-formulated cannabinoid products. on Nov 21, 2018.See details»
Medicinal Excellence in Neurological Disorders, LLC ... - Crunchbase
Nov 21, 2018 · Medicinal Excellence in Neurological Disorders, LLC a cannabinoid research company focused on the development of physician-formulated cannabinoid productsSee details»
Medicinal Excellence in Neurological Disorders - CB Insights
Medicinal Excellence in Neurological Disorders is a cannabinoid research company that develops physician-formulated cannabinoid products along with proprietary delivery devices and …See details»
Cannabuff | Jushi Acquires MEND. Plans to Work with Local …
Sep 26, 2020 · Jushi Inc., has acquired MEND (Medicinal Excellence in Neurological Disorders, LLC), a Buffalo-based cannabis research company. The deal added Laszlo L. Mechtler, a …See details»
Medicinal Excellence in Neurological Disorders - CB Insights
See Medicinal Excellence in Neurological Disorders funding rounds, investors, investments, exits and more. Evaluate their financials based on Medicinal Excellence in Neurological Disorders's …See details»
Improving access to medicines for neurological disorders
Jul 22, 2024 · Using epilepsy and Parkinson disease as tracer conditions, it highlights the wide unavailability and unaffordability of these medicines, explores the different health system …See details»
Transforming Drug Development for Neurological Disorders: …
Oct 12, 2023 · There is an urgent need to advance new and innovative therapeutic approaches and drug development tools for neurological disorders.See details»
Improving access to medicines for neurological disorders
To align with the IGAP target for 80% of countries to provide essential medicines for neurological disorders in primary care by 2031, a new WHO report, published on July 22, proposes …See details»
Global synergistic actions to improve brain health for human ...
May 19, 2023 · In this Perspective, we highlight the global burden of neurological disorders and propose pragmatic solutions to enhance neurological health, with an emphasis on building …See details»
Mental health: neurological disorders - World Health Organization …
May 3, 2016 · Neurological disorders are diseases of the central and peripheral nervous system. In other words, the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, …See details»
Over 1 in 3 people affected by neurological conditions, …
Mar 14, 2024 · A major new study released by The Lancet Neurology shows that, in 2021, more than 3 billion people worldwide were living with a neurological condition. The World Health Organization (WHO) contributed to the analysis of …See details»
Cell therapy for neurological disorders | Nature Medicine
Oct 15, 2024 · With all the remarkable new approaches to treat neurological disorders, we take a critical look at the state of current clinical trials and how challenges may be overcome with the …See details»
Health Science Leaders Join Forces to Accelerate Development of ...
Dec 4, 2019 · Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health …See details»
The global burden of neurological disorders: translating evidence …
Dec 5, 2019 · The GBD findings should place prevention of neurological disorders as the main priority for public-health authorities, neurology services as a main priority for health-care …See details»
Global, regional, and national burden of disorders affecting the ...
Mar 14, 2024 · Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.See details»
Tackling the growing burden of neurological disease
Jan 24, 2024 · In May 2022, the World Health Organization adopted the Intersectoral global action plan on epilepsy and other neurological disorders 2022-2031 (IGAP), which aims to improve …See details»
Improving access to medicines for neurological disorders
Neurological disorders are the leading cause of disability globally and access to essential medicines for neurological disorders remains a critical global health challenge. Disorders such …See details»
The Lancet Neurology: Neurological conditions now leading cause …
Mar 14, 2024 · Neurological conditions were responsible for 443 million years of healthy life lost due to illness, disability, and premature death (disability-adjusted life years) in 2021, making …See details»
WHO calls for better access to medicines to reduce vast treatment …
Jul 22, 2024 · A new WHO report, Improving Access to Medicines for Neurological Disorders, sets out the barriers that prevent access to these essential medicines, and presents a framework …See details»
Macamides as Potential Therapeutic Agents in Neurological …
Sep 25, 2024 · Therapeutic treatment of nervous system disorders has represented one of the significant challenges in medicine for the past several decades. Technological and medical …See details»